Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
allogeneic
4:58
Challenges to address in the CAR-T field
John Rossi
• 26 Aug 2021
2:54
Development of personalized tissue-engineered veins
Petter Björquist
• 14 Oct 2021
3:16
Future advancements in tissue engineering
Petter Björquist
• 14 Oct 2021
1:10
How personalized tissue-engineered veins can overcome transplantation problems
Petter Björquist
• 14 Oct 2021
4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine
• 28 May 2021
4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini
• 20 May 2021
5:05
Hypoimmunogenic iPSCs: avoiding immune rejection
Sonja Schrepfer
• 27 May 2021
2:01
Cardiosphere-derived cells in myocardial regeneration
Linda Marban
• 19 May 2021
3:48
Challenges in developing cord blood- and cord tissue-based therapies
Joanne Kurtzberg
• 22 Jun 2021
4:55
Advances in cell-based therapies for MS
Jakob Dupont
• 17 Jun 2021
5:20
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS
Jakob Dupont
• 17 Jun 2021
4:08
Characterization of ATA188: an off-the-shelf therapy for MS
Jakob Dupont
• 17 Jun 2021
4:28
Optimizing blood supply chain management in cell & gene therapy
Delara Motlagh
• 1 Jun 2021
1:40
Innovations within the CAR T-cell field
Hong Ma
• 19 Feb 2021
2:56
Allogenic NKX101 in r/r AML
James Trager
• 22 Feb 2021
3:38
Avoiding immune rejection of allogeneic iPSCs
Sonja Schrepfer
• 27 May 2021
1
2
Next